Protalix Biotherapeutics' Series B Round

Protalix Biotherapeutics raised a round of funding on March 28, 2005. Investors include Pontifax.

Protalix Biotherapeutics is a biopharmaceutical company that is focused on the development and commercialization of proprietary recombinant therapeutic proteins expressed through its proprietary ProCe…

Articles about Protalix Biotherapeutics' Series B Round: